Brodalumab, a Human Anti-Interleukin-17 Receptor A Monoclonal Antibody, Shows Low Immunogenicity in Patients with Moderate-to-Severe Psoriasis

Main Article Content

Kristian Reich
Mark Lebwohl
Carle Paul
Mads Ropke
Monika Rosen
Klaus Hansen

Keywords

psoriasis, brodalumab, clinical trial

Abstract

Abstract not available.

 

This study was supported by Amgen/AstraZeneca. This poster was sponsored b y LEO Pharma.

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 > >>